ArticleOncoTargets and therapy2016
Pemetrexed plus dendritic cells as third-line therapy for metastatic esophageal squamous cell carcinoma.
Bin Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this paperpooled itcites it